[Immunosuppressive therapy].
D000470:Alkaloids / Q000627:therapeutic use; D000477:Alkylating Agents / Q000627:therapeutic use; D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use; D000917:Antibody Formation; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D057487:Enzyme Therapy; D005493:Folic Acid Antagonists / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D011241:Prednisone / Q000627:therapeutic use; D011742:Pyrimidine Nucleotides / Q000627:therapeutic use; D051381:Rats; D013866:Thioguanine / Q000627:therapeutic use
D000470:Alkaloids; D000477:Alkylating Agents; D000903:Antibiotics, Antineoplastic; D000961:Antilymphocyte Serum; D005493:Folic Acid Antagonists; D007166:Immunosuppressive Agents; D011742:Pyrimidine Nucleotides; D013866:Thioguanine; D001379:Azathioprine; D011241:Prednisone
Immunsuppressive Therapie.